Skip to main content
Adastra Holdings logo

Adastra Holdings — Investor Relations & Filings

Ticker · XTRX ISIN · CA00654D2095 LEI · 549300SKMLMH3FJ3AF32 CSE Manufacturing
Open in API
Filings indexed 489 across all filing types
Latest filing 2021-09-01 Regulatory Filings
Country CA Canada
Listing CSE XTRX

About Adastra Holdings

https://adastraholdings.ca/

Adastra Holdings is a manufacturer and supplier of ethnobotanical and cannabis products for the lawful adult-use and medical markets. The company specializes in the extraction and processing of cannabis, offering a portfolio that includes concentrates, vape pens, wax, resin, and infused pre-rolls. Adastra manufactures products for its proprietary brands, such as Phyto Extractions and Endgame Extracts, and provides co-manufacturing services for partners. A core operational advantage is the co-location of Adastra Labs with Chemia Analytics, an in-house licensed analytical testing and consulting laboratory. This integrated facility ensures rigorous quality control, compliance, and efficient product development, emphasizing a scientific and refined approach to extraction methodologies.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing that Adastra Holdings Ltd. has submitted an application for a Controlled Substances Dealer's License to Health Canada, which is under review. It discusses the company's business activities, the license application process, and expected timelines for approval. There are no financial statements, detailed financial performance data, or regulatory certifications included. The document is an update on a regulatory/licensing matter rather than a financial report or detailed management discussion. It is not a report itself but an announcement of a regulatory application status. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2021-09-01 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a detailed term sheet for a debenture issuance by CU Inc., including information on principal amount, coupon, maturity, redemption terms, ratings, and syndicate details. It references a final base shelf prospectus and provides specific financing terms and conditions. This type of document is characteristic of a Capital/Financing Update, as it relates to the issuance of new debt securities and provides detailed information about the financing terms. It is not an annual or interim report, nor an announcement of a report publication. It is not a regulatory filing or a proxy statement. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2021-09-01 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings
2021-08-30 English
Interim MD&A - English.pdf
Regulatory Filings
2021-08-30 English
Interim financial statements/report – English.pdf
Regulatory Filings
2021-08-30 English
News release - English.pdf
Regulatory Filings
2021-08-27 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.